Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Patent
1991-12-10
1994-11-29
Ellis, Joan
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
435 693, 4351723, 4352402, 536 2372, 4241861, 4241991, 4242291, 530350, 935 9, 935 32, 935 34, 935 57, 935 63, 935 65, 935 70, C12N 700, C12N 1500, C12P 2102, C12P 1934
Patent
active
053690257
ABSTRACT:
A recombinant fowlpox virus is disclosed which is useful as a vaccine for protection against Marek's Disease. The recombinant virus preferably contains a gene for one or more Marek's Disease Virus antigens such as glycoprotein B homologue, glycoprotein C homologue, glycoprotein D homologue, glycoprotein H homologue and tegument proteins, under the control of a poxvirus promoter within a region of the DNA of fowlpox virus which is not essential for virus growth.
REFERENCES:
patent: 5021347 (1991-06-01), Yasui et al.
Lewin Science vol. 237 (1987) Sep. 25, 1987.
Reeck et al. Cell vol. 50 Aug. 28, 1987.
Churchill et al, Nature, vol. 221, pp. 744-747 (1969).
Schat et al, J. Natl. Cancer Inst., vol. 60, No. 5, pp. 1075-1081 (1978).
Blacklaws et al, Virology, 177:727-736 (1990).
Boyle et al, Virus Research, vol. 10, pp. 343-356 (1988).
Ogawa et al, Vaccine, vol. 8, pp. 486-490 (1990).
Okazaki et al, "Protection Against Marek's Disease by Vaccination with a Herpesvirus of Turkeys", pp. 413-429 (1970).
Rispens et al, "Control of Marek's Disease in the Netherlands . . . Laboratory Vaccination Trials", pp. 108-125.
Witter et al, Avian Pathology, 8:145-156 (1979).
Yuen et al, Proc. Natl. Acad. Sci. USA, vol. 84, pp. 6417-6421 (1987).
Sanger et al, Proc. Natl. Acad. Sci. USA, vol. 74, No. 12, pp. 5463-5467 (1977).
Tsurushita et al, Gene, 62:135-139 (1988).
Shirakawa et al, Gene, 28:127-132 (1984).
Silva et al, Virology, vol. 136, pp. 307-320 (1984).
Ross et al, J. gen. Virol., 70:1789-1804 (1989).
Yanagida et al, Journal of Virology, vol. 66, No. 3, pp. 1402-1408 (1992).
Nazerian et al, Journal of Virology, vol. 66, No. 3, pp. 1409-1413 (1992).
Ross et al, Journal of General Virology, vol. 72, No. 4, pp. 939-947 (1991).
Proceedings XIX World's Poultry Congress, Amsterdam, The Netherlands, (1992), vol. 1, pp. 144-149.
Davison et al. J. Mol. Biol.(1980) 210, 771-784.
Davison et al. J. Mol. Biol. (1980) 210, 749-769.
Lee Lucy F.
Li Yi
Nazerian Keyvan
Ogawa Ryohei
Yanagida Noboru
Ellis Joan
Nippon Zeon Co. Ltd.
The United States of America as represented by the Secretary of
LandOfFree
Recombinant fowlpox vaccine for protection against Marek's disea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant fowlpox vaccine for protection against Marek's disea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant fowlpox vaccine for protection against Marek's disea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-73605